If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

Share Price is delayed by 15 minutes
Get Live Data
14.00    0.00 (0.00%)
Bid:
13.50
Ask:
14.50
Spread: 1.00 (7.407%)
Market Cap: £11.55m
FIPP Live PriceLast checked at - London Stock Exchange

Intraday Frontier Ip Share Chart

DIT hails Frontier IP's Portuguese success

5 Oct 2018 07:00

RNS Number : 0374D
Frontier IP Group plc
05 October 2018
 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

 

Department for International Trade hails Frontier IP's Portuguese success

 

 

The UK Department for International Trade ("DIT") has recognised Frontier IP's success in Portugal by presenting the Group with the New to Market Award at the 10th anniversary of the DIT Business Awards in the country.

 

The award caps a year when the Group, which provides a range of commercialisation services to university spin outs in return for equity stakes, incorporated its first Portuguese portfolio company, a result of its formal relationship with the Universidade Nova de Lisboa Faculty of Science and Technology ("FCT Nova").

 

NTPE is developing novel technology called Paper-E to print electronic circuits, sensors and semiconductors onto paper. More than 65 researchers are working on the project, and the Group holds a 31.6 per cent stake in the company.

 

Frontier IP also has a formal relationship with the Universidade de Évora and recently struck a partnership agreement with the British Embassy in Lisbon, which will provide strategic support to the Group.

 

HM Trade Commissioner for Europe Andrew Mitchell and Christopher Sainty, HM Ambassador to Portugal, presented the award to Frontier IP chief executive officer Neil Crabb at the Ambassador's residence in Lisbon.

 

The DIT Business Awards, first launched in 2008, rewards and recognises UK companies who have achieved success in Portugal and the entrepreneurial effort of Portuguese companies which have chosen to invest in the UK.

 

Other UK companies to win awards included AstraZeneca, Barclays, Colt and Leonardo Helicopters.

 

HM Ambassador to Portugal Christopher Sainty said: "We are really quite proud to celebrate the business achievements of Frontier IP in Portugal and our modest contributions to their success. Congratulations."

 

Frontier IP Chief Executive Officer Neil Crabb said: "We are honoured the DIT has recognised Frontier IP's work in Portugal as we strive to reach our goal to be a leading IP commercialisation partner in the country. The DIT's support has been invaluable and we look forward to building on our strong relationships with the Department and Portuguese universities."

 

 

ENQUIRIES

 

Frontier IP Group Plc

T: 0131 240 1251

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

Company website: www.frontierip.co.uk

 

M: 07464 546 025

Allenby Capital Limited (Nominated Adviser and Broker)

T: 0203 328 5656

Nick Athanas / Nicholas Chambers (Corporate Finance)

Amrit Nahal (Equity Sales)

 

Kreab (Financial PR)

T: 020 7074 1800

Robert Speed / Matthew Jervois

 

ABout frontier IP

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAEALELESFPFFF
Date   Source Headline
30th Jun 20265:00 pmRNSTotal Voting Rights
26th Jun 202610:03 amRNSHolding(s) in Company
25th Jun 20262:44 pmRNSHolding(s) in Company
25th Jun 20267:00 amRNSHolding(s) in Company
24th Jun 20267:00 amRNS-RPortfolio news: Investment in Fieldwork Robotics
23rd Jun 20267:00 amRNSPosting of Circular and Notice of General Meeting
19th Jun 20267:00 amRNSResult of Retail Offer
17th Jun 20267:00 amRNSResult of Placing and Subscription
16th Jun 20265:20 pmRNSRetail Offer
16th Jun 20264:58 pmRNSProposed Placing and Subscription
26th May 20267:00 amRNS-RPortfolio news: Dekiln strategic partnership
5th May 20267:00 amRNSAppointment of Chief Financial Officer
16th Apr 20264:07 pmRNSHolding(s) in Company
15th Apr 20267:00 amRNSPortfolio News: 2D Photonics subsidiary grant
13th Apr 20262:35 pmRNSHolding(s) in Company
10th Apr 202610:30 amRNSUpdate re Investee Company
8th Apr 20267:00 amRNS-RPortfolio news – Fieldwork Robotics £3M fundraise
31st Mar 20265:18 pmRNSHolding(s) in Company
30th Mar 20267:00 amRNSUnaudited Half Year Results
23rd Mar 20267:00 amRNS-RAlusid reaches milestone in European roll out
28th Jan 20264:28 pmRNSHolding(s) in Company
19th Jan 20267:00 amRNS-RPortfolio news - Strong results for TVG vaccine
12th Jan 202610:30 amRNSHolding(s) in Company
31st Dec 20251:00 pmRNSTotal Voting Rights
31st Dec 20251:00 pmRNSTotal Voting Rights
31st Dec 202512:30 pmRNSResult of AGM
31st Dec 202512:30 pmRNSResult of AGM
29th Dec 20252:37 pmRNSHolding(s) in Company
29th Dec 20252:37 pmRNSHolding(s) in Company
24th Dec 20259:52 amRNSHolding(s) in Company
24th Dec 20259:52 amRNSHolding(s) in Company
24th Dec 20257:00 amRNSHolding(s) in Company
23rd Dec 20252:17 pmRNSDirectors' Shareholdings
23rd Dec 20252:17 pmRNSDirectors’ Shareholdings
22nd Dec 20253:48 pmRNSResult of Retail Offer
22nd Dec 20253:48 pmRNSResult of Retail Offer
18th Dec 20259:15 amRNS-RDekiln benefits from £3 million funding
17th Dec 202511:54 amRNSResult of Placing and Subscription
17th Dec 20257:01 amRNSRetail Offer
17th Dec 20257:00 amRNSProposed Placing and Subscription to raise £870k
15th Dec 20257:00 amRNS-RPortfolio news- Alusid £500k pre-IPO funding round
10th Dec 20254:56 pmRNSHolding(s) in Company
9th Dec 20257:00 amRNSPosting of Annual Report & Notice of AGM
8th Dec 20257:00 amRNSFinal results for the year ended 30 June 2025
2nd Dec 20257:00 amRNS-RAlusid signs Swedish distribution agreement
6th Nov 20257:00 amRNSBord Change
3rd Nov 20257:00 amRNS-RTVG demonstrates success in animal trials
20th Oct 20257:00 amRNS-RAmprologix raises £740,000 in Pre-Series A round
25th Sep 20257:00 amRNSBoard Changes
24th Sep 20255:12 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.